Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Reminder Deadline for Stepan NYSESCL Stock Dividend Approaching

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Finance_ Trading ratings today (2)
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Investors have until Wednesday to buy Stepan (NYSE:SCL) stock if they want to receive the upcoming quarterly dividend of 37.5 cents per share. The ex-dividend date is on Thursday, so anyone who owns the stock before then will be eligible for the payout. Shareholders who hold SCL by the end of Wednesday’s trading session will qualify for the dividend, which is set to be distributed on March 15, 2024.

SCL Stock Price Update: February 26, 2024 – Analysis and Insights

On February 26, 2024, SCL stock experienced a slight decrease in its price, closing at $90.00. This represented a $1.01 drop from the previous market close, which equates to a 1.11% decrease in value. Despite this decrease, SCL is still trading in the middle of its 52-week range and above its 200-day simple moving average.

The stock remained unchanged in after-hours trading, indicating that investors may be taking a wait-and-see approach before making any significant moves. Investors should always conduct thorough research and analysis before making any investment decisions. By staying informed and staying disciplined in their investment strategies, investors can make more informed decisions and potentially achieve greater success in the stock market.

SCL Stock Performance Analysis: Revenue Decline and Net Loss Reported in Fourth Quarter

On February 26, 2024, SCL stock experienced a mixed performance based on the latest financial data provided by CNN Money. The company reported a total revenue of $2.33 billion for the past year, which marked a 16.14% decrease compared to the previous year. In the fourth quarter, the total revenue was $532.13 million, reflecting a 5.35% decrease from the previous quarter.

In terms of net income, SCL reported $40.20 million for the past year, representing a significant 72.68% decrease from the previous year. However, in the fourth quarter, the company reported a net loss of $1.19 million, which was an improvement from the previous quarter.

Earnings per share (EPS) for SCL stood at $1.75 for the past year, showing a 72.57% decrease from the previous year. In the fourth quarter, the company reported a negative EPS of -$0.05, which remained flat compared to the previous quarter.

Tags: SCL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Credit

Trustco Bank Declares Quarterly Dividend of 36 Cents per Share

Short Interest in Crown Holdings NYSE CCK Declines by 83

From Novice to Expert: Navigating the Cryptocurrency Learning Curve

Title Milestone Pharmaceuticals Inc NASDAQ MIST Surges on Plans to Resubmit NDA for Etripamil

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com